The AI Health Arms Race: A Critical Perspective on Big Tech and the Widening Global Health Equity Gap.

The first quarter of 2026 witnessed an unprecedented convergence, with OpenAI, Anthropic, Microsoft, Google, and Apple launching or advancing dedicated artificial intelligence health platforms. ChatGPT Health, Claude for Healthcare, Copilot Health, Med-Gemini, and Apple Health+ collectively represent a paradigm shift toward AI-mediated personal health management, integrating electronic health records, wearable device data, and conversational AI in privacy-isolated environments. However, these tools are primarily designed for high-income country markets, with limited infrastructure, insufficient multilingual support beyond dominant global languages, and minimal cultural adaptation for low- and middle-income countries. This commentary critically examines the emerging AI health chatbot landscape through the lens of global health equity, analyzing structural barriers, including data poverty, regulatory vacuums, and the risks of data colonialism, whereby large technology corporations extract health data from populations in low- and middle-income countries without proportionate benefit sharing or local capacity building. We propose policy recommendations spanning international governance, national regulatory development, mandatory multilingual content, pre-market clinical safety evaluations, and multilateral financing of digital health infrastructure. We further discuss the strategic responsibilities of both high-income country technology corporations and governments in low- and middle-income countries in bridging this divide. Without deliberate equity-centered governance, the AI health arms race risks widening, rather than narrowing, the global health divide.